Cardiologist Q&A: Transcatheter Aortic Valve Replacement (TAVR) for Low-Risk Patients

Learn about the use of transcatheter aortic valve replacement (TAVR) for patients at low surgical risk from Dr. Robert Bonow, Professor of Cardiology at Northwestern Medicine. Since posting this video, the results of two low-risk trials - PARTNER 3 and Evolut - have been favorably received by the medical community. It is believed that TAVR devices for low-risk patients may be approved by the FDA shortly. (Video posted on May 18, 2018)